天源迪科(300047) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥746,733,459.08, representing an 18.05% increase year-on-year[7]. - Net profit attributable to shareholders was ¥39,864,954.58, up 82.31% compared to the same period last year[7]. - The net profit after deducting non-recurring gains and losses was ¥36,128,846.58, a significant increase of 616.57% year-on-year[7]. - Basic earnings per share for the reporting period was ¥0.0998, reflecting a 63.07% increase compared to the same period last year[7]. - The weighted average return on equity was 1.38%, an increase of 1.07 percentage points compared to the previous year[7]. - Total operating revenue for Q3 2018 reached ¥746,733,459.08, an increase of 18.06% compared to ¥632,533,892.11 in the same period last year[42]. - Net profit for the period was ¥44,264,481.33, representing a 69.94% increase from ¥26,066,306.05 in Q3 2017[43]. - Earnings per share (EPS) for the quarter was ¥0.0998, compared to ¥0.0612 in the previous year, reflecting a growth of 63.93%[44]. - The total profit for the period was CNY 101,492,511.52, compared to CNY 48,178,792.56 in the previous period, marking a growth of 110.7%[51]. Cash Flow and Liquidity - Cash flow from operating activities for the year-to-date was ¥48,029,744.93, an increase of 74.06%[7]. - Cash and cash equivalents at the end of the reporting period were ¥171,554,003.54, a decrease of 50.33% compared to the beginning of the year, primarily due to repayment of bank loans[19]. - Cash inflow from operating activities totaled approximately 2.27 billion CNY, compared to 1.79 billion CNY in the previous year, marking an increase of 27.3%[56]. - Cash outflow from operating activities was approximately 2.22 billion CNY, up from 1.76 billion CNY, representing an increase of 26.2% year-over-year[56]. - The ending cash and cash equivalents balance was approximately 151.55 million CNY, compared to 137.23 million CNY at the end of the previous year[59]. - The company reported a net cash outflow from investing activities of approximately 127.82 million CNY, compared to a net inflow of 65.41 million CNY in the previous year[58]. - Cash and cash equivalents at the end of the period totaled 61,885,447.23 CNY, down from 97,062,002.50 CNY year-over-year[62]. - The company reported a decrease in cash and cash equivalents by 137,733,972.21 CNY during the quarter[62]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥4,206,702,100.55, an increase of 2.73% compared to the end of the previous year[7]. - Cash and cash equivalents decreased from RMB 345.41 million at the beginning of the period to RMB 171.55 million at the end of the period, a decline of approximately 50.3%[34]. - Total liabilities increased from RMB 1.18 billion to RMB 1.22 billion, an increase of approximately 3.4%[36]. - The company's equity attributable to shareholders rose from RMB 2.83 billion to RMB 2.89 billion, an increase of about 2.4%[36]. - Accounts receivable decreased from RMB 1.39 billion to RMB 1.29 billion, a reduction of about 7.7%[34]. - Total other receivables at the end of the reporting period were ¥62,720,181.39, an increase of 54.46% compared to the beginning of the year, mainly due to increased payments for bidding and quality assurance deposits[19]. - Fixed assets at the end of the reporting period were ¥404,392,814.59, an increase of 65.63% compared to the beginning of the year, primarily due to the completion of construction at the Hefei R&D base[20]. Investments and Expenses - Research and development expenses for the reporting period were ¥149,210,634.31, an increase of 56.94% compared to the same period last year, due to increased R&D investment and consolidation of Weenbert[21]. - The company reported an investment loss of ¥-1,365,990.83 for the reporting period, compared to a profit of ¥2,941,384.48 in the same period last year, mainly due to reduced profits from joint ventures[22]. - Research and development expenses increased to CNY 149,210,634.31, up 57% from CNY 95,077,785.01 in the previous period, indicating a strong focus on innovation[49]. - The company recorded a tax expense of CNY 7,443,397.12, significantly higher than CNY 1,665,441.04 in the previous period, reflecting increased profitability[51]. Shareholder Information - The company reported a total of 21,483 common shareholders at the end of the reporting period[11]. - The top shareholder, Chen You, holds 10.16% of the shares, with 30,416,973 shares pledged[11]. - The company did not engage in any repurchase transactions among the top shareholders during the reporting period[12]. - There were no overdue commitments from major shareholders or related parties during the reporting period[27]. - The company reported no violations regarding external guarantees during the reporting period[29]. Future Outlook - The company plans to invest up to RMB 400 million in the construction of the second phase of the Hefei R&D base[25]. - The company has no plans for significant changes in net profit compared to the same period last year[28].